Galecto Inc expected to post a loss of 41 cents a share - Earnings Preview

Damora Therapeutics

24/04/2024 14:23

* Galecto Inc  GLTO.OQ   GLTO.O  is expected to show no
change in
quarterly revenue when it reports  results on April 26
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Galecto Inc is for a
loss
of 41 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 10.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Galecto Inc
is
$6.00​, above​ its last closing price of $0.70. ​​​

This summary was machine generated April 24 at 13:23 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)